SCHEMBL5081555

SCHEMBL5081555

CCCCC1N(CC2CCCCC2)OOC12CCN(C(=O)OCc1ccccc1)CC2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 6/20 0.51
SMN1; SMN2 Q16637 3/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
OPRD1 P41143 1/20 0.43
HTT P42858 1/20 0.43
FAAH O00519 1/20 0.42
CYP2C19 P33261 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
BCHE P06276 1/20 0.40
USP19 O94966 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
GRIN2B Q13224 1/20 0.39
PRCP P42785 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4465064 0.84 CCR5 (0.53) CCR5SMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL4465069 0.84 CCR5 (0.51) CCR5SMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL4461843 0.83 CCR5 (0.60) CCR5SMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL5081558 0.83 CCR5 (0.51) CCR5SMN1; SMN2NPC1RAB9AOPRD1
SCHEMBL13597265 0.76 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9AHTTFAAH
SCHEMBL13604578 0.76 CCR5 (0.57) CCR5
SCHEMBL4458368 0.72 CCR5 (0.49) CCR5SMN1; SMN2NPC1RAB9AHTT
SCHEMBL27012546 0.72 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9AHTTCYP2C19
SCHEMBL13519706 0.72 SMN1; SMN2 (0.67) SMN1; SMN2NPC1RAB9AHTTFAAH
SCHEMBL13661148 0.71 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9AHTTFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7332500-B2 Heterocyclic antiviral compounds ROCHE PALO ALTO LLC 2008-02-19 US disclosed
EP-1716156-A2 CHEMOKINE CCR5 RECEPTOR MODULATORS F.HOFFMANN-LA ROCHE AG (CH) 2006-11-02 EP disclosed
WO-2005075484-A2 CHEMOKINE CCR5 RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2005-08-18 WO disclosed